UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 1, 2008
AMERIGON INCORPORATED
(Exact name of registrant as specified in its charter)
Michigan | 0-21810 | 95-4318554 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
21680 Haggerty Road, Ste. 101, Northville, MI | 48167 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (248) 504-0500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the follow provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 250.13e-4(c)) |
Section 1. Not applicable.
Section 2. Financial Information.
Item 2.02 | Results of Operations and Financial Condition |
On April 30, 2008, Amerigon Incorporated (the Company) publicly announced its first quarter financial results for the period ended March 31, 2008. A copy of the Companys news release is filed as Exhibit 99.1 to this report and is incorporated in this report by reference. The information in this Section 2, Item 2.02 and the attached exhibit shall not be deemed filed for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly stated by specific reference in such filing.
Sections 3-8. Not applicable.
Section 9. Financial Statements and Exhibits
Item 9.01 | Financial Statements and Exhibits |
Exhibit 99.1 | Company News Release dated April 30, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERIGON INCORPORATED | ||
By: | /s/ BARRY G. STEELE | |
Barry G. Steele, | ||
Chief Financial Officer |
Date: May 1, 2008
Exhibit Index
99.1 | Company news release dated April 30, 2008. |
Exhibit 99.1
Advanced Thermoelectric Solutions |
NEWS RELEASE for April 30, 2008 at 6:00 AM EDT
Contact: | Allen & Caron Inc | |
Jill Bertotti (investors) | ||
jill@allencaron.com | ||
Len Hall (media) | ||
len@allencaron.com | ||
(949) 474-4300 |
AMERIGON REPORTS 2008 FIRST QUARTER RESULTS
Strong Demand for CCS Drives Record Quarterly Revenues and Unit Shipments
NORTHVILLE, MI (April 30, 2008) . . . Amerigon Incorporated (NASDAQ: ARGN), a leader in developing and marketing products based on advanced thermoelectric (TE) technologies for a wide range of global markets and applications, today announced another quarter of record revenues and a record number of units shipped for its first quarter ended March 31, 2008.
Revenues for this years first quarter reached record levels increasing to $17.4 million, up from $16.3 million for last years first quarter due to continued strong demand for the Companys proprietary Climate Control Seat (CCS) system in an increasing number of vehicle models. Gross margin as a percentage of revenue for the 2008 first quarter was 32.0 percent consistent with 32.0 percent in the 2007 first quarter. Net income for this years first quarter was $1.4 million, or $0.06 per share, compared with net income in last years first quarter of $1.3 million, or $0.06 per share.
This years first quarter results included year-over-year increases in research and development expenses of approximately $500,000 due to the addition of CCS engineering resources to support the large number of upcoming new vehicle programs, continued development of new automotive and non-automotive TE-based products and increased activities at Amerigons BSST subsidiary. The Company expects that net research and development expenses will increase during the remainder of 2008 and in 2009 as it continues to step up its development activities at BSST to support continued development of its advanced TE technology.
Our first quarter of 2008 was another very solid quarter, and it followed our strong performance at the close of 2007, said President and Chief Executive Officer Daniel R. Coker. This was particularly significant because it came in tough economic times, especially within the automobile industry in general. We believe this is a great endorsement of our heated and cooled seat system and our thermoelectric technology, which has a broad base of potential applications in a number of attractive markets worldwide.
We also marked an important milestone in the expansion of our product line during the 2008 first quarter with the initial shipments of our newly developed heated and ventilated seat system for use in a new vehicle model for the Asian market, Coker added.
Amerigon also received very modest revenues from the first commercial product outside the automotive market the C2 personal heater/cooler being manufactured and distributed by Herman Miller, which worked on the design with BSST. The C2 began shipping in late 2007. Coker said that Amerigon expects to announce the commercialization of another TE-based product in a different market in July of this year.
Higher CCS sales in the first quarter of this year were primarily the result of new model introductions and higher penetration on certain models. New models launched with CCS since last years first quarter include the Jaguar XJ, Jaguar XF, Lincoln MKS and two Nissan vehicle models not yet announced. A portion of higher sales was attributable to the Lincoln MKX and Lincoln MKZ which, beginning with the 2008 model year, began to install CCS as a standard feature where they had previously been offered as an option.
The move from an option to standard feature on these two vehicles is another strong sign of the growing acceptance of our heated and cooled seat system by not only the automotive manufacturer, but the car buyer as well, added Coker. We continue to believe that our seat system will continue to gain acceptance as more people are introduced to the value enhancing, year-round comfort it provides.
During this years first quarter, Amerigon announced three new vehicle model introductions the Lincoln MKS, Hyundai Genesis and Lexus LS 570. This brings the total number of vehicles currently offering CCS to 26 automotive models produced by Ford, General Motors, Toyota, Nissan, Honda and Hyundai. Coker noted that the Company expects to make several additional announcements during the year, representing more vehicle introductions in 2008 than in any other year in the past.
While this years first quarter revenues were not materially affected by the much publicized American Axle strike, this years second quarter revenues could be depending on the extent of the strike.
The trend towards a more balanced distribution of revenue between North American and international customers continued during the 2008 first quarter. Revenue from European and Asian customers in this years first quarter increased to 47 percent of total revenue, up from 37 percent in the 2007 first quarter, and revenue from North American customers in the 2008 first quarter was 53 percent of total revenue compared to 63 percent in last years first quarter.
Unit shipments of CCS systems for the 2008 first quarter increased to a record 253,000, up from 240,000 units for the year-earlier period. As of March 2008, the Company had shipped approximately 3.8 million CCS units to customers since 2000.
The Companys balance sheet as of March 31, 2008 remained strong with cash, cash equivalents, short-term and long-term investments totaling $25.7 million, total assets of $58.7 million, no bank debt and shareholders equity of $45.1 million.
During this years first quarter, Amerigon reclassified a portion of its investments in Auction Rate Preferred Stock totaling $22.0 million to long-term investments from short-term investments due to ongoing liquidity issues in the auction rate securities market. Amerigon believes the value of these investments has not declined and expects that a portion of the assets will be redeemed by their issuers at par over the next few quarters. The Companys current operating forecast provides for favorable free operating cash flow. Borrowings under the Companys $20 million revolving credit line would provide ample resources should any short term need for liquidity arise.
Guidance for 2008
The Company reconfirmed that it expects product revenues in 2008 to increase 30 to 40 percent over 2007 with continued strong increases in profitability. The growth in 2008 is expected to be primarily driven by additional new program launches and the full year effect of model launches in 2007. These effects are expected to be partially offset by lower volumes on existing programs resulting from general softness in the North American automotive market.
In 2008, there will continue to be a number of macro-economic and geopolitical issues outside Amerigons control, such as the effects of gas price increases, the uncertainty of the situations in the Middle East and the Gulf Region, and the availability of credit, that could negatively impact the automotive industry, the overall economy and Amerigons results.
Conference Call
As previously announced, Amerigon is conducting a conference call today to be broadcast live over the Internet at 11:30 AM Eastern Time to review the financial results for the first quarter ended March 31, 2008. The dial-in number for the call is 1-800-762-8779. The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Amerigons website at www.amerigon.com.
About Amerigon
Amerigon (NASDAQ: ARGN) develops products based on its advanced, proprietary, efficient thermoelectric (TE) technologies for a wide range of global markets and heating and cooling applications. The Companys current principal product is its proprietary Climate Control Seat (CCS) system, a solid-state, TE-based system that permits drivers and passengers of vehicles to individually and actively control the heating and cooling of their respective seats to ensure maximum year-round comfort. CCS, which is the only system of its type on the market today, uses no CFCs or other environmentally sensitive coolants. Amerigon maintains sales and technical support centers in Southern California, Detroit, Japan, Germany and England.
Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Companys actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to Amerigons Securities and Exchange Commission filings and reports, including, but not limited to, its Form 10-Q for the period ended March 31, 2008 and its Form 10-K for the year ended December 31, 2007.
TABLES FOLLOW
AMERIGON REPORTS 2008 FIRST QUARTER RESULTS
Page 4-4-4
AMERIGON INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
Three Months Ended March 31, |
||||||||
2008 | 2007 | |||||||
Product revenues |
$ | 17,360 | $ | 16,273 | ||||
Cost of sales |
11,801 | 11,059 | ||||||
Gross margin |
5,559 | 5,214 | ||||||
Operating expenses: |
||||||||
Research and development |
2,399 | 1,727 | ||||||
Research and development reimbursements |
(809 | ) | (584 | ) | ||||
Net research and development expenses |
1,590 | 1,143 | ||||||
Selling, general and administrative |
2,127 | 2,153 | ||||||
Total operating expenses |
3,717 | 3,296 | ||||||
Operating income |
1,842 | 1,918 | ||||||
Interest income |
297 | 186 | ||||||
Other income |
52 | 50 | ||||||
Earnings before income tax |
2,191 | 2,154 | ||||||
Income tax expense |
820 | 860 | ||||||
Net income |
$ | 1,371 | $ | 1,294 | ||||
Basic earnings per share |
$ | 0.06 | $ | 0.06 | ||||
Diluted earnings per share |
$ | 0.06 | $ | 0.06 | ||||
Weighted average number of shares basic |
22,004 | 21,390 | ||||||
Weighted average number of shares diluted |
22,784 | 22,363 | ||||||
MORE-MORE-MORE
AMERIGON REPORTS 2008 FIRST QUARTER RESULTS
Page 5-5-5
AMERIGON INCORPORATED
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands, except share data)
March 31, 2008 |
December 31, 2007 |
|||||||
(unaudited) | ||||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash & cash equivalents |
$ | 2,563 | $ | 1,170 | ||||
Short-term investments |
1,150 | 23,925 | ||||||
Accounts receivable, less allowance of $400 and $542, respectively |
12,766 | 11,672 | ||||||
Inventory: |
||||||||
Raw materials |
168 | 329 | ||||||
Finished goods |
3,002 | 1,890 | ||||||
Inventory |
3,170 | 2,219 | ||||||
Deferred income tax assets |
3,935 | 3,784 | ||||||
Prepaid expenses and other assets |
737 | 595 | ||||||
Total current assets |
24,321 | 43,365 | ||||||
Property and equipment, net |
4,524 | 3,965 | ||||||
Long-term investments |
22,025 | | ||||||
Deferred financing costs |
8 | 9 | ||||||
Patent costs, net of accumulated amortization |
2,789 | 2,679 | ||||||
Deferred income tax assets |
5,069 | 5,968 | ||||||
Total assets |
$ | 58,736 | $ | 55,986 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current Liabilities: |
||||||||
Accounts payable |
$ | 9,799 | $ | 8,640 | ||||
Accrued liabilities |
3,210 | 3,987 | ||||||
Deferred manufacturing agreement current portion |
200 | 200 | ||||||
Total current liabilities |
13,209 | 12,827 | ||||||
Deferred manufacturing agreement long-term portion |
400 | 450 | ||||||
Total liabilities |
13,609 | 13,277 | ||||||
Shareholders equity: |
||||||||
Common Stock: |
||||||||
No par value; 30,000,000 shares authorized, 22,127,035 and 21,917,733 issued and outstanding at March 31, 2008 and December 31, 2007, respectively |
63,847 | 63,028 | ||||||
Paid-in capital |
21,983 | 21,766 | ||||||
Accumulated other comprehensive income foreign currency |
(5 | ) | (16 | ) | ||||
Accumulated deficit |
(40,698 | ) | (42,069 | ) | ||||
Total shareholders equity |
45,127 | 42,709 | ||||||
Total liabilities and shareholders equity |
$ | 58,736 | $ | 55,986 | ||||
MORE-MORE-MORE
AMERIGON REPORTS 2008 FIRST QUARTER RESULTS
Page 6-6-6
AMERIGON INCORPORATED
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Three Months Ended March 31, |
||||||||
2008 | 2007 | |||||||
Operating Activities: |
||||||||
Net income |
$ | 1,371 | $ | 1,294 | ||||
Adjustments to reconcile net income to cash provided by operating activities: |
||||||||
Deferred tax provision |
748 | 817 | ||||||
Stock option compensation |
217 | 218 | ||||||
Depreciation and amortization |
307 | 119 | ||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(1,094 | ) | (1,417 | ) | ||||
Inventory |
(951 | ) | 2,465 | |||||
Prepaid expenses and other assets |
(141 | ) | (34 | ) | ||||
Accounts payable |
1,159 | 670 | ||||||
Accrued liabilities |
(777 | ) | (125 | ) | ||||
Net cash provided by operating activities |
839 | 4,007 | ||||||
Investing Activities: |
||||||||
Purchases of investments |
(3,100 | ) | (9,325 | ) | ||||
Sales and maturities of investments |
3,850 | 5,876 | ||||||
Purchase of property and equipment |
(874 | ) | (94 | ) | ||||
Patent costs |
(153 | ) | (89 | ) | ||||
Net cash used in investing activities |
(277 | ) | (3,632 | ) | ||||
Financing Activities: |
||||||||
Proceeds from the exercise of Common Stock options |
820 | 90 | ||||||
Net cash provided by financing activities |
820 | 90 | ||||||
Foreign currency effect |
11 | 6 | ||||||
Net increase in cash and cash equivalents |
1,393 | 471 | ||||||
Cash and cash equivalents at beginning of period |
1,170 | 2,440 | ||||||
Cash and cash equivalents at end of period |
$ | 2,563 | $ | 2,911 | ||||
# # # #